Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

ted timely or receive FDA approval; risks that the launch of BYDUREON will be delayed or unsuccessful; risks that we will not be successful in our efforts to expand the reach of our sales force or in our efforts to secure an exenatide development and commercial partner outside the U.S.; risks that our expense reductions will not be as large as we expect; and other risks inherent in the drug development and commercialization process. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for BYETTA, SYMLIN or BYDUREON. These and additional risks and uncertainties are described more fully in the Company's recently filed Form 10-Q. Amylin disclaims any obligation to update these forward-looking statements.

(Financial information to follow)AMYLIN PHARMACEUTICALS, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)Quarter ended
December 31, Twelve months ended
December 31, 2011201020112010Revenues:  Net product sales

$ 160,867$ 162,315$ 621,570$651,113  Revenues under collaborative agreements

4,06811,87529,10817,700Total revenues

164,935174,190650,678668,813Costs and expenses:  Cost of goods sold

12,31814,04248,37661,687  Selling, general and administrative

78,32362,548271,224276,880  Research and development

27,67137,510161,215183,083  Collaborative profit sharing

43,08363,071222,545257,127  Net costs to reacquire economic
interest in exenatide products

431,587-431,587-  Restructuring

1,7077,3287,19016,780Total costs and expenses

594,689184,4991,142,137795,557Operating loss

(429,754)(10,309)(491,459)(126,744)Interest and other expense, net

(31,717)(8,874)(51,940)(25,570)Net loss

$(461,471)$ (19,183)$(543,399)$(152,314)Net loss per share - basic and diluted

$ (3.15)$ (0.13)$ (3.73)$
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... SAN DIEGO , Sept. 30, 2014   ... company developing a minimally invasive real-time 3D Cardiac Chamber ... sources that cause and / or sustain complex cardiac ... additional $26.2M financing to continue developing its imaging/mapping system ... portfolio.  The financing will allow Acutus Medical to complete ...
(Date:9/30/2014)... , Sept. 30, 2014  Life Science ... focused on supporting promising emerging biotech, medical device, ... named the Top Angel Investment Group in the ... the best performer out of 370 angel groups ... performance, network strength (connections), selection aptitude and brand ...
(Date:9/30/2014)... , Sept. 30, 2014  Synapse Biomedical Inc. ( ... enrollment of the post-approval study of its NeuRx ... needed to meet the FDA enrollment requirement was ... of schedule.  The NeuRx DPS®, which is the ... for ALS patients, is a humanitarian device that ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... 12 Today at the annual AdvaMed medical ... of Good Promotional Practices software, announced a partnership ... and case management solutions. Together, the companies will ... help Life Sciences companies cope with the myriad ...
... Merial, the Animal Health division of the sanofi-aventis Group (EURONEXT: ... Animal Health Co. (China) held a ground-breaking ceremony for an ... Development Zone, China. Merial Animal Health Co. (China), a ... in China has been in operation for almost 20 years. ...
Cached Medicine Technology:Prolifiq and EthicsPoint Announce Partnership: 'Automatic Alerts' Help Life Sciences Engage in Good Promotional Practices 2Prolifiq and EthicsPoint Announce Partnership: 'Automatic Alerts' Help Life Sciences Engage in Good Promotional Practices 3Merial invests US $70 million in Nanchang, China 2Merial invests US $70 million in Nanchang, China 3
(Date:9/30/2014)... A new report launched today by the Intellectual ... on Ageing) conducted by academics from the School ... has highlighted the serious, complex and unique health ... , The IDS-TILDA study is the first study ... one in the world with the ability to ...
(Date:9/30/2014)... September 30, 2014 SIMpalm, the top ... iPhone App for another great social networking music sharing ... App for iPhone®, iPad®, and iPod touch®. The App ... of music from their pre-populated ITunes account. This app ... song’s album art or photo of their choice to ...
(Date:9/30/2014)... 30, 2014 MyServer2Go.com made ... the Best VPS Hosting this year for its quality ... affordable price. , MyServer2Go.com is a professional and ... hosting services. And this announcement will help webmasters find ... to MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is one of ...
(Date:9/30/2014)... The Buffet Restaurants industry ... drop in industry revenue in 2009, the industry has ... has been negatively affected by low levels of consumer ... presented itself in the form of increasing health consciousness. ... tend to use lower quality ingredients in the food ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 The ... to improve breast cancer risk prediction and to ... a study published in Breast Cancer Research (BCR ... density and breast cancer risk: a case-control study ... strong connection between breast density and breast cancer ...
Breaking Medicine News(10 mins):Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Buffet Restaurants in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Buffet Restaurants in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4
... the Canadian Institute of Medicine it was found that fat formed ... lack a balanced diet which in turn results in various ill ... daily calories from fat which is the main cause of various ... people and questioned them about their food habits. ,Statistics ...
... from schools have met with criticism from anti-obesity lobby ... to make all schools to be soft drink-free by ... described as "misguided and based on weak evidence" by ... physicians at Starship and Auckland University. ,Professor ...
... 55 others were afflicted with the disease in Chhajli village ... an eight-year-old boy and aged woman and illness of others ... Medical teams were pressed into service today., ,Civil Surgeon ... rushed to the village to educate the people about preventive ...
... for their aches and pains could be at an ... of a new study// . ,Researchers said ... dose of acetaminophen showed abnormalities in blood tests, which ... had come across liver damage in patients who took ...
... institutes and increase the number of seats in existing facilities ... well as accommodate// the central government's proposed quota policy, says ... of seats in medical institutions and open more institutes in ... more than 4,000 doctors and this was the only to ...
... the Calcutta High Court claiming that the failure of West ... directives in keeping the metropolis clean had led to the ... has died and several others are suffering from dengue with ... ,The petitioner's lawyer Idris Ali claimed before a division ...
Cached Medicine News:Health News:Anti-Obesity Groups Criticize Response of Medical Professionals 2Health News:Even Normal Doses Of Tylenol Could Damage Liver 2
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... technology allows the grasper ... a shorter length and ... the stone. The Unidex ... one-handed operation. Supplied sterile ...
Bugbee Fulgurating...
Fulgurating Electrode, 2 F...
Medicine Products: